These included β-catenin-mediated transcription-related CALCOCO1 [56], breast cancer poor-prognosis marker SBEM [57,58], and SMARCC2, a member of SWI/SNF chromatin-remodeling complex interacting with BRCA1 [59]. Here, SMARCC2 is linked to breast cancer.